1. False Biomarker Discovery due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125. (1st February 2014) Authors: Prassas, Ioannis; Brinc, Davor; Farkona, Sofia; Leung, Felix; Dimitromanolakis, Apostolos; Chrystoja, Caitlin C; Brand, Randall; Kulasingam, Vathany; Blasutig, Ivan M; Diamandis, Eleftherios P Journal: Clinical chemistry Issue: Volume 60:Number 2(2014) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modifying the Non-Modifiable: Single-Dose Hepatic-Targeted siRNA Leads to Sustained Decreases in Plasma Lp(a). (6th October 2022) Authors: Blasutig, Ivan M Journal: Clinical chemistry Issue: Volume 68:Number 10(2022) Page Start: 1348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Phoenix Rises: The Rebirth of Cancer Immunotherapy. (6th January 2020) Authors: Blasutig, Ivan M; Farkona, Sofia; Buchbinder, Elizabeth I; Luke, Jason J; Sharma, Padmanee; Sznol, Mario Journal: Clinical chemistry Issue: Volume 63:Number 7(2017) Page Start: 1190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗